Tower Research Capital LLC (TRC) - TEKMIRA PHARMACEUTICALS CORP ownership

TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 41 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TEKMIRA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$63,000
-32.3%
5,300
-0.2%
0.01%
-45.5%
Q1 2015$93,000
+675.0%
5,312
+554.2%
0.01%
+1000.0%
Q4 2014$12,000
+200.0%
812
+325.1%
0.00%
Q3 2014$4,000
-60.0%
191
-74.1%
0.00%
-100.0%
Q2 2014$10,000
-44.4%
737
-11.4%
0.00%
-50.0%
Q1 2014$18,000
-41.9%
832
-78.8%
0.00%
-60.0%
Q4 2013$31,000
+244.4%
3,916
+204.7%
0.01%
+400.0%
Q3 2013$9,0001,2850.00%
Other shareholders
TEKMIRA PHARMACEUTICALS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$279,596,00015.57%
RA Capital Management 2,714,800$47,400,0004.71%
Alpha Wave Global, LP 2,221,000$38,779,0001.90%
Redmile Group, LLC 700,000$12,222,0001.10%
HealthCor Management, L.P. 718,800$12,550,0000.60%
Monashee Investment Management LLC 55,000$960,0000.60%
SPHERA FUNDS MANAGEMENT LTD. 298,486$5,212,0000.54%
Telemetry Investments, L.L.C. 48,000$838,0000.46%
Anson Funds Management LP 25,000$437,0000.39%
Blue Ridge Capital, L.L.C. 1,700,000$29,682,0000.34%
View complete list of TEKMIRA PHARMACEUTICALS CORP shareholders